This report demonstrates the use of major histocompatibility complex (MHC) class II dextramers for detection of autoreactive CD4 T cells in situ in myelin proteolipid protein (PLP) 139-151-induced experimental autoimmune encephalomyelitis (EAE) in SJL mice and cardiac myosin heavy chain-α (Myhc) 334-352-induced experimental autoimmune myocarditis (EAM) in A/J mice. Two sets of cocktails of dextramer reagents were used, where dextramers 
Introduction
The use of major histocompatibility complex (MHC) class II tetramers for detection of antigen-specific CD4 T cells has been a challenge [1] [2] [3] [4] [5] [6] [7] . To enhance the detection sensitivity of MHC class II tetramers, the research team has created next-generation tetramers, designated "dextramers" 8 . Dextramers contain dextran backbones in which multiple streptavidin-fluorophore moieties are conjugated, such that several peptide-tethered, biotinylated MHC monomers can be attached to one dextran molecule 9 . Thus, large aggregates of MHC dextramers that contain several MHCpeptide complexes can interact with multiple T cell receptors (TCRs).
This group recently generated dextramers for various self-antigens and demonstrated that the detection sensitivity of dextramers was approximately five-fold more than tetramers 8 . The experimental systems include experimental autoimmune encephalomyelitis (EAE) induced with proteolipid protein (PLP) 139-151 in SJL mice; EAE induced with myelin oligodendrocyte glycoprotein (MOG) 35-55 in C57Bl/6 mice; and experimental autoimmune myocarditis (EAM) induced with cardiac myosin heavy chain-α (Myhc) 334-352 in A/J mice. This study demonstrates the use of PLP 139-151-and Myhc 334-352 dextramers to detect antigen-specific CD4 T cells in situ with specificity by developing a direct staining protocol, thereby eliminating the need to amplify the signals from using fluorophore antibodies, an approach commonly employed with the use of tetramers. In addition, a comprehensive method of evaluating tissues has also been devised to reliably enumerate the frequencies of antigen-specific CD4 T cells in situ 10 . Detection of antigen-specific T cells in situ permits delineation of events caused by specific antigenic stimuli from those caused by bystander activation. Likewise, the in situ technique also provides opportunities to track the kinetics of antigenspecific T cell infiltrations in the target organs.
Induction of EAE
1. To induce EAE, prepare the peptide/complete Freund's adjuvant (CFA) emulsion as described in 11 with the following modifications:
Step 1.1:
prepare PLP 139-151 at a concentration of 1 mg/ml in 1x phosphate buffered saline (PBS 
Clinical Scoring of EAE Mice and Harvesting of Cerebrums
1. Monitor the animals for appearance of clinical signs, and score the disease-severity daily from day 9 postimmunization as follows: 0 -healthy; 1 -limp tail or hind limb weakness but not both; 2 -limp tail and hind limb weakness; 3 -partial paralysis of hind limbs; 4 -complete paralysis of hind limbs; 5 -moribund or dead 12 . 2. Euthanize the mice when they reach a neurological score of 3 or 4 using CO 2 . To euthanize the mice, pre-fill the euthanasia chamber first with CO 2 by turning the regulator of the CO 2 tank not exceeding 6 psi and allow animals to stay within the chamber for approximately 5 min to achieve complete asphyxia. Soak the euthanized animals in 70% alcohol. Immediately, place the animals on an absorbent pad and using a pair of sterile forceps and scissors expose the hearts by cutting through the thoracic cavity. Puncture the right auricles and perfuse by injecting 10 ml of cold 1x PBS into the left ventricles of the hearts. 3. Excavate the skull by snipping the cranium in a circular fashion using a pair of curved scissors, and carefully, flip the skull bones with forceps.
Harvest the brain by blunt dissection and using a clean scalpel, separate cerebrum from the cerebellum. Place the cerebrum in a tube containing cold 1x PBS and leave the tube on ice until processing. 5. In the meantime, place the tissue chambers one per well of a 24-well plate. Fill the wells containing the tissue chambers with 1 ml of cold 1x PBS, and leave the plate on ice. 1. Prepare the tissue chambers by attaching a thin nylon mesh to the cut-end of a 25 ml polypropylene pipette using super glue; after trimming the excess mesh around the pipette, cut the pipette to a length of 1 cm from the mesh.
In Situ
6. Lower the vibratome blade to the level of the top surface of tissue; set the vibratome speed to 0.22 mm/sec and start sectioning with a forward movement to make 200 µm thick sections. Transfer one cerebral section per well using a watercolor soft brush into the tissue chambers placed within the wells of a 24-well plate. Keep the plate on ice until sectioning is complete to prevent tissue degradation. Note: Follow these steps to obtain in total, three paired sections from three different regions of the brain dorsal to the ventral surface (Figure 2) . One section from each pair (in total three sections) placed in three individual tissue chambers are designated for staining with specific dextramers (IA s /PLP 139-151) and anti-CD4. Likewise, another set of three sections that are placed in three individual tissue chambers are designated for staining with control dextramers (IA s /TMEV 70-86) and anti-CD4.
7. Transfer the three tissue chambers containing the sections designated for staining with specific dextramers into three wells in a 24-well plate with one chamber per well in which, 300 µl of a cocktail containing allophycocyanin (APC)-conjugated PLP 139-151 dextramers (2.5 μg/ml) and anti-CD4-phycoerythrin (PE; 5 µg/ml) in blocking solution (1x PBS with 2% normal goat serum) was previously added. Cover the wells with a lid. 8. Similarly, transfer the three tissue chambers containing the sections designated for staining with control dextramers into three wells in a 24-well plate with one chamber per well in which, 300 µl of a cocktail containing APC-conjugated TMEV 70-86 dextramers (2.5 μg/ml) and anti-CD4-PE (5 µg/ml) in blocking solution was previously added. Cover the wells with a lid. Note: Refer to Massilamany et al., 8 for preparation of dextramers, and the dextran molecules to prepare dextramers were kindly provided by Immudex, Copenhagen, Denmark. 9. Label the wells, and wrap the plate with aluminum foil and place the plate on a rocking platform set to gentle rotations for 1.5 hr in the dark at RT. 10. After the incubation period, wash tissue sections on the rocking platform, by transferring the tissue chambers to a fresh well containing 1 ml of cold 1x PBS, and avoid dribbling the contents of one well into the other. Repeat washing thrice, allowing at least 10 min per wash. Ensure that the tissue sections do not get dried as they can stick to the sides of the chamber. 11. Fix the sections by transferring the tissue chambers into a fresh well in 24-well plate containing 1ml of filtered 4% PBS-buffered paraformaldehyde (pH 7.4) on a rocking platform for 2 hr with gentle rotations. 12. Repeat washing thrice as described in step 3.10. 13. Place the stained and fixed sections on a clean microscopic slide using a watercolor soft brush. Wipe excess water without touching the section, and mount the section using mounting medium. Cover with a microscopic coverslip and allow the slides to dry at RT O/N in the dark room.
Induction of EAM and Collection of Hearts
1. Induce EAM as described in reference 11 . 2. Euthanize the mice on day 21 postimmunization using clean chamber fitted with CO 2 gas cylinder, and soak the animals in 70% alcohol.
Immediately, place the animals on an absorbent pad and using a pair of forceps and scissors expose the hearts by cutting through the thoracic cavity. Puncture the right auricles and perfuse by injecting 10 ml of cold 1x PBS into the left ventricles of the hearts. Collect the hearts and place in tubes containing cold 1x PBS. 2. Place the heart in a disposable deep base mold histology cassette kept on ice, and pour molten 40 °C agarose until the tissues are completely submerged as described in step 3.2. 3. Follow step 3.3. 4. Trim excess agarose from all the sides of the embedded tissue and slightly expose the base of the heart. Smear vibratome tissue block with super glue and transfer the agarose-embedded tissue over the glued surface by placing the exposed surface of the heart over the glue. Do not move the tissue, once the tissue is set over the block. 1. Place the vibratome block containing the agarose-embedded tissue on ice, and allow the glue to dry for 15 min.
In Situ
5. Follow steps 3.5 and 3.6. 6. Transfer the heart sections using a watercolor soft brush into the tissue chambers placed within the wells of a 24-well plate. Keep the plate on ice until sectioning is complete to prevent degradation of tissue. Note: Follow these steps to obtain in total, eight paired sections from the apex to base of the heart (Figure 2) . Place all sections in tissue chambers, allocating up to 3 sections per chamber. One section from each pair (in total eight sections) is designated for staining with specific dextramers (IA k /Myhc 334-352) and anti-CD4. Likewise, another set of eight sections is designated for staining with control dextramers (IA k /RNase 43-56) and anti-CD4. 7. Transfer the three tissue chambers containing the sections designated for staining with specific dextramers into three wells in a 24-well plate with one chamber per well in which, 300 µl of a cocktail containing APC-conjugated Myhc 334-352 dextramers (2.5 μg/ml) and anti-CD4-PE (5 µg/ml) in blocking solution was previously added. Cover the wells with a lid. 1. Similarly, transfer the three tissue chambers containing the sections designated for staining with control dextramers into three wells in a 24-well plate with one chamber per well in which, 300 µl of a cocktail containing APC-conjugated RNase 43-56 dextramers (2.5 μg/ml) and anti-CD4-PE (5 µg/ml) in blocking solution was previously added. Cover the wells with a lid.
8. Label the wells, and wrap the plate with aluminum foil and place the plate on a rocking platform set to gentle rotations for 1.5 hr in the dark at RT. 9. Follow steps, 3.10 to 3.11 10. Repeat washing thrice as described in step 3.10. 11. Place the stained and fixed sections (up to three sections/slide) on a clean microscopic slide using a watercolor soft brush. Wipe excess water without touching the sections, and mount the sections using mounting medium. Cover with a microscopic coverslip and allow the slides to dry at RT O/N in the dark room. 12. Store the slides in a light-proof slide storage box at 4 °C. 1. Use Nikon A1-Eclipse 90i confocal microscope system for routine scanning and acquisition of images.
Analysis of Dextramer
To start Click open, the NIS Elements AR software (version 4.13). 1. Choose "TRITC" and "Cy5" channels from the panel. The excitation/emission wavelengths respectively for TRITC and Cy5 channels, 561.5 nm / 553-618 nm and 640.7 nm / 663-738 nm appear by default. 2. Assign the pseudocolors "green" and "red" for the TRITC (CD4-PE) and Cy5 (dextramer-APC) channels, respectively. 3. Place the slide to be examined on the microscopic stage and focus manually under 100X magnification. Set the "HV" to 110 and offset to "0". Click "Focus" and adjust the "voltage" to optimize the lasers. 4. Click "Focus"; scan the section from top to bottom, and set the 'Z' level for image acquisition. Click "CH series" and acquire the image sequentially. Identify dext + CD4 + T cells appearing as yellow punctate cells based on co-localization of signals generated from both the red (dextramers) and green (CD4) channels.
2. Use Olympus FV500-BX60 confocal microscope for easy quantitative enumeration of dext + CD4 + T cells.
To begin click open, the FLUOVIEW software (version 4.3). 1. Select the dyes "Cy3" and "Cy5" from the drop-down menu, and click "apply" to load the respective lasers. Note: the excitation/emission wavelengths for Cy3 (543 nm/pseudocolored "green"; CD4-PE) and Cy5 (633 nm/pseudocolored "red"; dextramer-APC) channels. 2. Place the slide to be examined on the microscopic slide, and focus it manually under low magnification (4X or 10X). Click "Focus" while the Cy3 laser is on, and focus the inflammatory focus. 3. Change the objective to 100X magnification. Set the file size to "512/512" from the drop-down menu. Click "Focus" and adjust the values for "PMT", "Gain" and "Offset" parameters to optimize the lasers separately for Cy3 and Cy5. 4. Click "Z stage" and then click "Focus" while both the lasers are on. Set the thickness of the "Z stage" by clicking the "up" and "down" arrows. Set the "Z" interval to 2 µm. 5. Click "Stop", and choose "Seq123". Then, click "XYZ" and start acquiring "Z" series images for the selected area within the inflammatory focus. Save the "Z serial images" as AVI files. To save image files, select the image from the "Z serial image", and then save as "tiff" format. 4. Examine 10 to 15 inflammatory foci per section in cerebrum, and in each focus, acquire a set of 15 to 25 serial images sequentially. 1. Examine a total of 20 inflammatory foci from all the eight sections of heart and from each focus acquire 10 to 15 serial images sequentially. Take the 'Z' serial images by scanning the slides in a 'horizontal-vertical up-horizontal-vertical down' movement so that repetition of 'Z' series within the same focus is avoided. 2. Once 'Z' serial images are captured, name the files by identifying the slide numbers, name of the sections, and the number of the 'Z' serial images taken. 
Representative Results
In this report, in situ detection of antigen-specific, autoreactive CD4 T cells by direct staining with MHC class II dextramers is described. This study was further extended to demonstrate the use of dextramer reagents for detecting antigen-sensitized T cells in situ in EAM induced with Myhc 334-352 in A/J mice, which is also a T cell-mediated disease 13, 14 . Eight paired heart sections were obtained, each 200 µm thick, from EAM mice (Figure 2) . From each pair, one section (with a total of 8 sections) was stained with Myhc 334-352 dextramers and anti-CD4, whereas another set of sections (8 in total) was stained with RNase 43-56 dextramers (control) and anti-CD4. Twenty sets of 'Z' serial images corresponding to that many inflammatory foci representing all eight sections were acquired sequentially as above (Figure 2) . Essentially, a given set of 'Z' serial images consisted of 10 to 15 individual represented one single inflammatory focus. Analysis of these images by LSCM showed the presence of cells positive for Myhc 334-352 dextramers (red), and CD4 (green) and expectedly, the cells bound with both dextramers and CD4 appeared as yellow punctate cells (Figure 3, top panels) . The background staining for control dextramers was negligible (Figure 3, bottom  panels) . The total numbers of dext + CD4 + T cells and the total number of CD4 + T cells were determined for each section and counts from all the sections were added together to derive the total number for each subset (dext + CD4 + T cells; CD4 + T cells). 
Discussion
Unlike MHC class I tetramers, the use of MHC class II tetramers for routine applications continues to be challenging, especially to enumerate the precursor frequencies of low-affinity autoreactive CD4 T cells, due in part to their activation dependency 6, [15] [16] [17] . Recently, this problem was circumvented by creating the next generation of tetramers, called "dextramers," permitting us to detect antigen-specific CD4 T cells for a number of autoantigens, such as PLP 139-151, MOG 35-55 and Myhc 334-352 8 . In this report, for the first time, the utility of MHC class II dextramers to detect and quantify self-reactive CD4 T cells in situ has been demonstrated using brain sections from EAE mice, and heart sections from EAM mice. On a reaction basis, dextramers offer the advantage of requiring a small amount of MHC/peptide complexes. In this protocol, each reaction requires only 0.75 µg of MHC/peptide monomers. In addition, staining with dextramers is a one-step reaction, since dextramers are coincubated with anti-CD4, and the whole procedure, from tissue sectioning to staining, can be finished in less than a day. In contrast, the published protocols for in situ staining with conventional tetramers commonly involve amplification procedures in which the fluorescent signals are amplified using secondary antibodies for fluorophores. As a result, staining procedures may take up to three days to complete [18] [19] [20] . Furthermore, the use of dextramers in cerebral sections permits detection of antigen-specific T cells deep in the tissue sections, even up to 50 µm. It was noted that PLP 139-151 dext + CD4 + cells were found to be located both perivascularly and also within the parenchyma. Furthermore, the intensity of signals generated from Myhc 334-352 dextramers was low in cardiac sections when compared with the PLP 139-151 dextramers in brain sections (Figure 1) , and such a variation may reflect the characteristics unique to each organ. One such variable is the lipid content which is present in high amounts in the brain tissue as opposed to cardiac tissue that contains mainly striated muscle fibers that can potentially restrict easy diffusion of dextramers into the inflammatory focus. In support of this notion, Myhc 334-352 dext + cells were detected only to a depth up to 20 µm in majority of cardiac sections. Additionally, Myhc 334-352 dext + cells were present scattered all through the myocardium suggesting the diffused nature of inflammatory infiltrates in myocarditic lesions.
Generally, two major factors can negatively influence the detection of antigen-specific T cells in situ by LSCM. First, insufficient signals emitted by fluorophores can lead to the need to amplify the signals using fluorophore antibodies. Second, such an indirect staining can undermine the specificity, as the background staining for control reagents also can increase proportionately 18, 19 . These limitations were circumvented by direct staining with the dextramers. Although, detection of CD4 T cells has been successfully shown with fresh sections, the use of dextramer reagents in frozen tissues requires additional studies, which can be a challenge as the retention of tissue-integrity may be difficult because of the tendency for tissues to get disintegrated during various staining steps 18, 19 .
